Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|October 9, 2017
How Is Mobile Health Changing the Health Care Landscape?
Moses Zoanna, CEO of Compliance Meds Technologies, discusses the impact of mobile health.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
FDA Approves Insulin Efsitora, Once-Weekly Basal Insulin Injection for Adults With T2D
4
Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests
5